School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Zai Lab Ltd ZLAB

Healthcare · Biotechnology

$23.10last close 2026-10-13 · market cap $21.86B · delayed data

Trailing returns

1M-4.31%
3M+17.74%
6M+8.25%
1Y-26.03%
5Y-77.38%

Basis: Adjusted daily closes.

What it does

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Open ZLAB in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies